Descripción
Greyledge Technologies is a clinical biotech company focused on autologous (from the patient) cell therapeutics including Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). Our unique process quantifies and controls cell populations within our products to refine and research customized treatments, specific to both patient and clinical application.